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Supplementary Methods 
Publically available GWAS data on 78,308 individuals on whom intelligence was measured 
was meta-analysed with the data from the INTERVAL1 study. The INTERVAL1 study is a 
prospective cohort study of ~50,000 participants drawn from blood donors.2 Recruitment occurred 
between 2012 and 2014 whereby blood donors aged 18 years and older consented to be recruited from 
the National Health Service Blood and Transplant (NHSBT) static donor centres across England. 
Participants are largely healthy as individuals as eligibility for donation is contingent upon being free 
from major disease (myocardial infarction, stroke, cancer etc.) and those who reported being unwell 
or having had recent illness or infection were not eligible for blood donation and so were not part of 
the INTERVAL sample. 
Participants agreed to take part in online questionnaires that contained lifestyle and health 
information, including self-reported height, weight, ethnicity, current smoking status, alcohol 
consumption, doctor-diagnosed anemia, use of medications (hormone replacement therapy, iron 
supplements) and menopausal status. The INTERVAL study was approved by the Cambridge (East) 
Research Ethics Committee and UK Biobank was approved by the North West Multi-centre Research 




DNA was extracted from whole blood using the buffy coat at LGC Genomics (UK) using a 
Kleargene method and samples of sufficient concentration and purity were aliquoted for shipment to 
Affymetrix for genotyping. Standard quality control (QC) procedures were implemented by 
Affymetrix during the genotyping pipeline. This included the excluding samples with a poor signal 
intensity (dish QC <0.82) along with samples that had a low call rate (< 0.97) based on 20,000 high 
quality probesets. Variants were excluded in the event that they had a call rate of <0.95, has more than 
three clusters, which indicates of-target measurement, had cluster statistics that were indicative of 
poor quality genotyping or multi-allelic variants that could not be called easily (Fisher’s linear 
discriminant, heterozygous cluster strength, homozygote ration offset were used). A total of 48,813 
participants from the INTERVAL sample were genotyped in 10 batches. Within-batch sample and 
variant QC was performed following standard Affymetrix QC exclusions. Non-best probesets were 
excluded to leave a single probeset per variant. Visual inspection of the cluster plots showed that 
some variants and minor allele homozygotes incorrectly called due to the presence of an extreme 
intensity outlier. Variants were failed from a batch in the event that there were fewer than 10 called 
minor allele homozygotes, the cluster plot contained at least one sample with an intensity at least 
twice as far from the origin as the second most extreme outlier, or if the outlying sample had an 
extreme polar angle (15o of > 75o) in the direction of the minor allele.  
 Samples that were not of European ancestry, as well as duplicate samples, were excluded 
prior to further QC of the variants within each batch using a set of high quality autosomal variants. 
These were defined as those with a minor allele frequency (MAF) >0.05, a Hardy-Weinberg 
equilibrium (HWE) p value of >1×10−6, or if there was r2 of ≤0.2 between pairs of variants. Duplicate 
samples were identified as those where π̂ ≥ 0.9 using Method-of-Moments IBD approach 
implemented in PLINK3. Non-Europeans were identified as those participants who had scores on PC1 
or PC2 of < 0 as derived using a principal components analysis conducted on the INTERVAL 
samples with the 1000 Genomes major ancestry populations.4 Variants that strongly deviated from 
HWE (p value <5×10−6), following a Fischer’s exact test for low-frequency and rare variants (Those 
with a MAF <0.05 across all ten batches) or those with a χ2 test for common variants were excluded 
from the batch. Finally, variants were also excluded from the batch in the event that they had a call 
rate of <0.97 (within-batch) and variants were dropped from all batches in the event that they failed in 
four of the ten batches due to either HWE deviation, low call rate, or failure in the Affymetrix 
exclusion criteria. These passing samples were then merged using the methods described by Jun et al. 
(2012)5 full details can be found in Astle et al. (2016).6 Non-autosomal and multi-allelic variants, and 
monomorphic variants were removed and the data were phased using SHAPEIT3 
(https://jmarchini.org/shapeit3/), to phase the data in chunks of 5,000 variants with a 250 variant 
overlap between chunks. Imputation was conducted using a combined 1000 Genomes Phase 3-
UK10K imputation panel with imputation being carried out on the Sanger Imputation Server for the 
43,059 participants that remained. 
 
 
Intelligence phenotype INTERVAL 
A general factor of cognitive ability was derived in INTERVAL using four tests. These were 
the Stroop Test (a measure of attention and reaction times), Trail Making Test B (a measure of 
executive function), Pairs Test (a measure of episodic memory), and a Reasoning test (a measure of 
intelligence). These tests have been adapted from the Cardiff Cognitive Battery7 and have been 
designed specifically for use in cognitive testing in epidemiology settings. Participants scores from 
each of these four tests was analysed using a principal components analysis where the first unrotated 
component was extracted. This component explained 48.0% of the variance in the test battery where 
each test loaded onto this single factor at 0.34-0.60. The effect of age (using fractional polynomials), 
sex and the effect of experiencing a stroke/TIA during the trial were controlled for using regression 
with the first unrotated principal component being the outcome variable. The residuals from this 
model were then used as the measure of intelligence for the 17,213 participants who had both 
genotype and phenotype data available. 
 
Genome-wide association analysis (GWAS) in the INTERVAL sample 
Individuals from INTERVAL who also took part in UK Biobank were identified using 
KING8; heterozygote concordance rate>  80% before being removed from the INTERVAL sample. A 
linear-mixed model was fit using BOLT-LMM9 and adjusted for the first five principal components of 
ancestry. The final sample size was 17,213 individuals. Following association analysis variants where 
the minor allele frequency (MAF) was <0.001 and an r2 of <0.6 were removed.  
 
Meta-analysis of INTERVAL data  
Publically available summary GWAS data on 78,30810 participants was downloaded. These 
data were meta-analysed using 17,213 participants of the interval consortium using a sample size 
weighted meta-analysis implemented in METAL.11 Following meta-analysis SNPs were removed if 
they were not present in both the INTERVAL sample and in the publically available data set on 
intelligence. SNPs were also excluded in the even that MAF <0.001. Z-scores were converted into 
beta weights using the equation, Beta <- Z-score/sqrt(2*MAF * (1-MAF) * (N+Z-score^2)), and 
standard errors were derived using SE <- 1/sqrt(2*MAF*(1-MAF) * (N+Z-score^2)).12 This yielded a 
total of 10,895,565 SNPs following meta-analysis in a sample of 95,521 individuals.
Supplementary Note 1. Results 
Functional annotation and gene based analysis of MTAG analysis of income 
Functional annotation of the loci identified using MTAG proceeded using the same methods 
used to investigate the income phenotype from UK Biobank.13 Firstly, it was found that 53.9% of the 
SNPs in the independent genomic loci were found in intronic regions and the 25.7% were found to be 
in intergenic regions with 14.6% being ncRNA intronic SNPs. As found in the analysis conducted 
without MTAG, these independent genomic loci are also predominantly found in regions of the 
genome involved in gene expression as indicated by 32.13% of the SNPs have an RDB score of <2 
and 80.12% have a minimum chromatin state of <8 (Supplementary Figure 2B-D & 
Supplementary Data 13). 
By examining these loci for overlap with those in GWAS Catalog we found that the loci 
identified using MTAG overlapped with those previously associated with intelligence (37 loci) and 
with education (65 loci). In addition we found that the loci linked to income were also associated with 
coronary artery disease and blood pressure phenotypes (7 loci) as well as with neuroticism (9 loci). 
Eleven loci previously linked to schizophrenia were linked to the loci associated with income and 2 
loci were also linked with subcortical brain region volumes (Supplementary Data 15). 
Gene-prioritization was also conducted on the income phenotype derived using MTAG. Here, 
a total of 1,317 genes were identified (Supplementary Figure 2E & Supplementary Data 16). A 
total of 392 genes were implicated using positional mapping with 529 implicated using eQTL 
analysis, with 1,006 genes identified using chromatin interaction mapping. 448 genes were implicated 
using two mapping strategies with 162 being identified using all three. Of the genes, 162 were 
identified across all three prioritization methods; 7 were of additional note as they are implicated 
through chromatin interactions between two independent genomic risk loci. These genes included 
ORC3 on chromosome 6, a gene known with links to neuronal proliferation, which was found 
implicated in a cross locus interaction in the tissues of hESC, IMR90, the Liver, Mesenchymal stem 
cell, and Mesendoderm tissues. ZNF589, NRBF2, and DPYD were also implicated by all three 
mapping strategies and chromatin interactions between two independent genomic risk loci in at least 
five tissue types (Supplementary Data 17). 
Using a gene-based GWAS conducted in MAGMA, 312 genes attained statistical significance 
after controlling for multiple tests (Supplementary Data 18), and 101 genes were implicated by all 
three mapping strategies and by the MAGMA gene based GWAS. 
Two gene sets were significant following correction for multiple testing neurogenesis (gene-
set size = 1,337, P = 1.67 × 10−6) and reactome pre notch transcription and translation gene set (gene-
set size = 25, P = 3.99 × 10−6) (Supplementary Data 19). The neurogenesis gene-set has been 
previously linked to intelligence14 and neuroticism,15 two phenotypes that show genetic correlations 
with income. This shared association between neuroticism, intelligence, and income, may therefore 
represent a biological system linked to all three phenotypes. It should be noted that this link between 
neurogenesis, neuroticism, intelligence, and income may be a case of mediated, or vertical, 
pleiotropy.16 
Gene-property analysis conducted on the MTAG-income phenotype replicated the link 
between gene expression in the brain and association with income (P = 1.05 × 10−11). A link was also 
identified between gene expression in the pituitary gland association with income (P = 7.72 × 10−11). 
The link between expression in the testis and income whilst nominally significant (P = 0.016) did not 
withstand correction for multiple tests using the MTAG-income phenotype (Supplementary Table 
10). This relationship between gene expression in the brain with differences in income was evident in 
twelve cortical tissue groupings the most significant of which were the brain cerebellar hemisphere (P 
= 3.05 × 10−12), brain cerebellum (P = 4.36 × 10−12), brain frontal cortex (P = 1.03 × 10−9), and the 
brain anterior cingulate cortex BA24 (P = 4.65 × 10−8) (Supplementary Data 20). A significant 
relationship was also found for gene expression in the early mid-prenatal developmental period and 
income (P = 0.002) (Supplementary Table 11) but no link was found with any of the age specific 
expression groupings (Supplementary Table 12). 
These relationships between income and gene expression across the cortex are also consistent 
with previous findings pertaining to intelligence,14 and so support the notion that intelligence is an 
intermediary phenotype between molecular genetic inheritance and individual difference in income.  
Partitioned heritability conducted using stratified LDSC produced similar, but more precise,  
findings to the non-MTAG analysis where a significant enrichment for income was found in 
evolutionarily conserved regions of the genome (P = 1.24 × 10−13). In addition, statistically significant 
enrichment was also found for the histone marks of H3K9ac peaks (P = 4.01× 10−4), and H3K4me1 
peaks (P = 4.79 × 10−4) as well is in this histone marks more broadly indicating a role for gene 
expression differences involved in income differences. Introns were also significantly enriched for 
income (P = 3.26 × 10−6). 
The MTAG analysis of the continuous categories also produced similar results to the initial 
analysis using only household income. The continuous categories by quintile showed that common 
variants that were in the first three quintiles for age (i.e. the younger three groupings) were associated 
with a greater proportion of the heritability of income (1st quintile P=1.00×10−7, 2nd quintile 
P=9.36×10−13, 3rd quintile P=3.39×10−27) as were SNPs in the upper two quintiles for background 
selection greater level of background selection (4th quintile P=5.63×10−22, 5th quintile P=2.59×10−9). 
As found for household income, the MTAG analysis of income also showed that first three quintiles 
describing nucleotide diversity and the same quartiles describing the level of LD (LDD-AFR) were 
also significantly enriched for heritability (Nucleotide diversity, 1st quintile P=1.23×10−40, 2nd quintile 
P=5.16×10−37, 3rd quintile P=9.57×10−6, LDD-AFR, 1st quintile P=2.43×10−19, 2nd quintile 
P=1.42×10−25, 3rd quintile P=2.41×10−5) (Supplementary Table 13). As with household income, the 
enrichment found by examining the continuous annotations by quintile is consistent with the idea that 
negative selective pressure has acted on the partially heritable traits linked to income. 
Consistent with the notion that MTAG derived a data set with associations that were specific 
to household income but with greater power, was the finding that cell-type specific enrichment using 
partitioned heritability showed the greatest level of enrichment for cell type specific groupings comes 
from the brain and central nervous system. Here, 29 cell types from brain and the rest of the central 
nervous system were significantly enriched using the gene expression data set (Supplementary Data 
21) compared with 24 using household income without MTAG (Supplementary Data 10). In 
addition one grouping “CD4.Positive.T.Lymphocytes”, from the blood or immune group, was found 
to harbour an enrichment of heritability (P=0.003) 
Furthermore, using the chromatin based sets, 41 of the 42 cell groupings that were 
significantly enriched were drawn from the brain and the central nervous system (Supplementary 
Data 22). The remaining significant chromatin based annotation was sourced from cell types that 
were expressed in the digestive tissues (Esoph-Muscularis_ENTEX__H3K4me3, P = 0.002).  
Three brain regions showed significant enrichment of heritability for income using the 
MTAG phenotype, Brain cerebellar hemisphere, P = 3.34×10−5, Brain cortex, P = 0.0004, and the 
Brain cerebellum, P = 0.001 (Supplementary Table 14). Lastly, gene expression associated with the 
category of neuron was found to be enriched for heritability (P=3.95×10−5) (Supplementary Table 
15). 
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Do your results mean that an individual’s level of income is 
determined at birth?  
No, our results do not imply that an individual is in some way predestined to end up earning a 
certain amount of money. We found just a small association between genetic variation and 
income variation in a very large sample. That small association means that, for the most part, 
even people with similar genes will end up with a range of different household incomes. But 
there is an ever-so-slightly higher likelihood that people with particular combinations of 
genetic variants will earn a higher income. 
 
The finding of genetic associations with a trait does not mean that environmental 
interventions cannot change them. That is, the idea of “genetic determinism” is completely 
false. A classic example of this is the disorder of phenylketonuria (PKU). This disorder is 
genetic in origin, and results in serious medical problems along with intellectual disability. 
However, by altering PKU patients’ diets from birth, people with this condition can lead lives 
that are not hampered by the disease, and don’t have a reduction in their cognitive abilities. 
Alternatively, consider eyesight. Having poorer eyesight is partly heritable, but this problem 
can be solved with an environmental intervention: spectacles. These examples show that, 
even if a trait is predominantly caused by genetic differences—and recall that income most 
certainly is not—this says nothing about whether it might be changed by environmental 
influences.  
 
Overall, anyone who interprets the finding that “genetic factors are associated with income 
(or any trait)” to mean “genes determine income (or any trait), and there’s nothing that can be 
done to change it”, has fundamentally misunderstood genetic research.  
What did you do in this study? 
We performed a “genome-wide association study”, or GWAS (pronounced “jee-was”). A 
GWAS is a type of study that searches for genetic variants that are linked to some outcome: 
they’ve been extensively used to find the genetic links to health conditions like 
cardiovascular disease and schizophrenia, and traits like height and weight. Our particular 
GWAS examined the outcome of household income, which might sound surprising since 
household income doesn’t—at least at first—appear to be a condition or a trait like those we 
just listed. We’ll explain this choice in more detail below. 
 
The genetic variants we just mentioned are called Single-Nucleotide Polymorphisms, or 
“SNPs” (pronounced “snips”). These are points on the DNA—many millions of them—
where people tend to differ in which nucleotide (which one of the four chemical “letters” of 
DNA: A, C, T, and G) is present. For example, 25% of people might have an “A” at that 
point on their DNA, whereas the remaining 75% have a “G”. This is the most common, 
though far from the only, way in which people differ in their DNA. A GWAS study lines up 
all the SNPs a person has and tests the extent to which each one is linked to the outcome of 
interest. In the case of height, each SNP might contribute a tiny fraction towards explaining, 
why some people are taller than others – contributing to bone length, say, or growth hormone 
production. 
 
We did our GWAS in DNA data from 286,301 people from across the United Kingdom, aged 
39-73 years. These were participants in the large-scale UK Biobank study. They had provided 
a large amount of information on their health and wellbeing, as well as a DNA sample. Our 
GWAS tested whether differences in household income were related to differences in SNPs. 
The first thing we did was the standard GWAS methodology as described above: we 
examined if people whose household income was higher, were more likely to have particular 
versions of each SNP in their genome.  
 
Our second analysis was to look at whether people who were generally more similar across 
all their SNPs were closer to each other in their income – this is one way of looking at the 
“heritability” of income. Heritability is the proportion of variation in the trait that is explained 
by all the genetic variants, in this case SNPs.  
 
Next, we combined our genetic data with information from other, previous studies on what 
genes are actually doing: how they are “expressed”, where specifically in the DNA they are 
located, and what biological functions they are thought to have. By doing so, we could try to 
understand the likely biological processes that any income-linked genetic variants were 
involved in. Finally, we looked at one likely psychological candidate for the link between 
DNA and income: intelligence, which is sometimes called cognitive ability or cognitive 
function. Our previous work had hinted that the reason DNA variants are associated with 
income in the first place is that—in part—they might predispose people to higher 
intelligence, which helps them attain higher incomes. Here, we used some more complex 
genetic statistical analyses that allowed us to look at which effects were causal – specifically, 
we checked whether part of the chain of causality was genes->intelligence->income. Even if 
we could find evidence to support this, we acknowledge that the chain would be far longer 
and more complicated than this, and would also include pathways that go from income-
>intelligence without any genes being involved. See below for more on what we mean by 
“intelligence”. 
 
What did you find? 
As we expected, the majority of the reasons people differed in their level of household 
income were not genetic. Our view is that those reasons are likely to be “environmental” – by 
this we mean, that the likely reasons are to do with anything that is not genetic: these include 
social conditions, economic policies like tax and benefit rates, pure luck, and so on. However, 
we did find a small association between genetic variation and variation in household income. 
We shall speculate as to why this might be in our answer to the next question. First, we’ll 
describe the results in more detail. 
 
We found that variation across all the SNPs measured in the current study from the UK 
Biobank sample accounted for 7.4% of the variation in household income. This is a small 
amount and other studies that have used methods to capture less common genetic variation 
have found heritability estimates for income between 40-50%.17 Therefore it is likely that our 
estimate, based only on common genetic variation, is an underestimation of the total genetic 
effect.  
 
The variation in income that is not due to genetic effects is likely due to environmental 
factors, as well as errors of measurement (for example, people often make mistakes filling in 
questionnaires, including questionnaires about income, and this creates some “noise” in the 
measure). Therefore, as we noted above, a large proportion of people’s differences in 
household income is likely to be environmental in origin, according to our results. 
 
We identified 30 regions of the genome (termed “loci”) that were associated with individual 
differences in household income (Figure 3). The SNPs within these loci showed evidence of 
being involved in gene-expression differences, and we identified that genes expressed in the 
brain and the synapse were associated with income (Figure 4 & Figure 5). We also found 
evidence that genes involved in neurogenesis, the process by which new neurons are formed, 
were associated with household income (Supplementary Note 1. Results). Whereas we were 
able to detect these differences each individual SNP had only a miniscule association with 
household income, even though each of them was statistically significant. 
 
We found that the genetic differences that were associated with higher household income (i.e. 
those that accounted for that 7.4% of household income variation) overlapped with the 
genetic differences that were linked to longer life, health, wellbeing, and intelligence (Figure 
6A, B & C). We found that the genetic variations that were linked to higher household 
income overlapped with the genetic differences that were associated with a lower risk of 
developing schizophrenia, ADHD, coronary artery disease, and feelings of tiredness and 
fatigue (Figure 6A, B & C).  
 
When we used the causal analysis mentioned above (a technique called Mendelian 
randomisation), we found evidence that being more intelligent was causally related to having 
a higher income. 
 
How could genetic differences be associated with something like 
household income? 
At first, it seems confusing that genetic differences might be associated with household 
income. A UK person’s income is a social variable, influenced by factors such as the 
socioeconomic position of their parents, the part of the country they happen to live in, how 
the economy is doing, politics and social policies, health and the physical environment, 
education, other factors, and, of course, luck.  
 
All of the factors we just listed and more are likely to play a role in people’s income levels – 
the reasons some people earn more money than others are complex. But on top of these, there 
are some individual traits and characteristics that might make a person more or less likely to 
earn a higher income. They might be more highly motivated and conscientious at work, for 
example, or they might be more intelligent, be less susceptible to illness, or simply more 
interested in the kinds of jobs that lead to higher wages. Some or all of these, along with other 
psychological and health factors, might be associated, to some extent, with genetic 
differences. Those genetic differences, which might have effects in the brain or in other parts 
of the body that are important for maintaining one’s health, might affect income via their 
effects on these other, “intermediate” traits, especially if these genetic variants have effects in 
the brain or in other parts of the body that are important for maintaining one’s health. In our 
study, we particularly focus on intelligence (or cognitive ability) as one of these potential 
factors, and we find it might account for some of the gene-income link. But this is not to 
gainsay the importance of all those other factors. 
 
What was the point of doing this research? 
The prompt for the study was our interest in health inequalities and how to ameliorate them. 
It is well known that people with a lower income are at greater risk of poorer health than 
those from more advantaged social backgrounds. Research into the reasons for these health 
differences investigates all the possible explanations for this link, be they environmental, 
genetic, or otherwise. For example, previous studies have shown that many common health 
problems are partly due to the genes that people inherit. A small part of the variation in social 
factors such as income also appears to be modestly associated with differences in their genes. 
Thus, one of the reasons genes might be related to income is that the genes cause health 
problems, which cause you to receive a lower income. We wanted to investigate whether the 
associations between income and health might, at least partly, be accounted for by people’s 
genetic differences that are associated with both income and health. If politicians or others 
wish to make effective policies to reduce the health inequalities between people of different 
social backgrounds, they need to know as much as possible about the mechanisms that 
produce these health inequalities. There is a great deal of extremely important research on the 
environmental factors that cause health and income inequalities. Our results make a small 
start at understanding the biological factors – which, to emphasize again, do not gainsay the 
existence or importance of environmental factors, and are themselves only a small part of the 
story of why people differ in their household income. 
 
Have you found “the money gene”? 
No, we have not found ‘the money gene’, or ‘the gene for income’. Income variation is a 
complex social measure, and it has many influences. Some potential influences on income—
such as some illnesses and some personal traits—are themselves partly heritable. It is 
possible that some genetic associations with such factors (health, personal traits etc.) are also 
picked up in a GWAS study of income. Therefore, our GWAS results should not be 
interpreted as indicating that there are close links between genetic variations and income 
differences. 
 
Moreover, there was no ‘gene for income’ in the sense that there was no large association 
between any individual genetic variant and differences in income. Genetic associations with 
factors such as household income (or height, or intelligence, or many common illnesses) are 
composed of many thousands of genetic variants, each with a tiny association – they all add 
up to form the overall genetic contribution to a trait or condition. 
 
Okay, so there’s no money gene, but is it fair to say you found the 
money genes? 
No, we did not find ‘money genes’. The reason for this is that we don’t think there can be 
direct genetic effects that act on social variables such as income; income and other measures 
of SEP are themselves the products of multiple factors and traits. Therefore, whereas the 
genes identified are associated with differences in income, they are also associated with other 
traits that may be causally related to income in Great Britain today. 
 
To whom do your results apply? You said that they were from UK 
Biobank, but what about other countries? 
Our findings were made in the context of Great Britain (that is, the participants were from 
England, Scotland, and Wales) in the modern era (that is, the participants filled in their 
questionnaire on their household income at some point within the past approximately ten 
years). In addition, our analysis was restricted to people who described their ethnic 
background as White. It will be interesting to test the extent to which the income-linked 
genetic variants we’ve found apply to people of different backgrounds, and those from 
different countries, cultures, and time periods, but for now, our data cannot speak to them. 
 
In addition, we should emphasize that the results we have found apply to what is currently the 
case Great Britain – not what could be the case, under different policies or economic 
circumstances. For example, a government could insist that everyone had the same income, at 
which point the genetic contribution to income differences would necessarily fall to zero. We 
do not attach any moral value to our findings: we are not arguing that people with “better 
genes” (whatever that would mean) are somehow getting their just deserts. Our findings are 
purely descriptive, and, although we note elsewhere that they can be used to inform policies 
that attempt to meliorate social inequalities, we do not take any view on what those policies 
should be. 
 
Your paper claims a “polygenic risk score” can “predict” income. What 
does this mean, if genes do not determine income as you state 
above? 
Another finding in our study was that we can take the results of our GWAS and create a so-
called “polygenic risk score” in a new, independent sample of people. This is essentially a 
summary of how many genetic variants a person has that give them a higher likelihood of a 
certain outcome – in our case, higher income. We found that 2.5% of the income differences 
in a new sample could be accounted for by this polygenic score. 
In statistics, the word “prediction” is often used differently from its common usage. 
Prediction would commonly refer to a statement regarding the future; however, in statistics, 
prediction can be used to transfer knowledge from one sample to another. In our study, we 
used knowledge of the genetic variants linked to income in UK Biobank (sample 1) to test if 
these same variants were linked to income in another sample, Generation Scotland (sample 
2). In doing so, knowledge of which genes were linked with income was transferred across 
these two samples. By testing whether the same genetic variants were associated with income 
in these two samples, we were able to link 2.5% of variation in income in Generation 
Scotland to the genetic effects identified in UK Biobank. Or, put another way, using the 
knowledge of which genetic variants were linked to income in UK Biobank, we were able to 
predict 2.5% of people’s income differences in Generation Scotland based solely on their 
DNA. 
 
Can we now tell what someone’s income is from their genes alone? 
No, polygenic risk scores used in our report cannot make accurate predictions of an 
individual person’s household income. The predictive ability of a polygenic risk score that 
only accounts for 2.5% of the differences in an outcome is extremely low, and this is even 
worse when applied to individual people. To put this another way, the score was not 
informative as to the remaining 97.5% of the variation in household income in the Great 
Britain today. As seen in Figure 7A, many of the individuals with a household income of 
<£10,000 had a greater polygenic risk score for income than those earning >£70,000. This is 
strong evidence against the idea that the genes we identify here “determine” a person’s 
income (and, as we noted above, we would argue that this logic applies to essentially all 
genetic influences). 
 
Aren’t genetic associations with income, however small, a sign of a 
society that is not meritocratic? 
Although such questions are unavoidable given that income was the main focus of the 
research, we did not directly address political, ethical, and moral issues like this one in our 
study. How one defines “meritocracy”, and the evidence one accepts to show the presence or 
lack of meritocracy in a society, will depend on one’s political priors, and we are not 
equipped or qualified to provide a discussion of political theory in this study or this FAQ 
document. However, it is important to note that our findings are descriptive, not prescriptive: 
none of the findings we describe should be read as saying that anyone “deserves” a particular 
income, since of course one does not “deserve” any particular set of genes one is given at 
conception. 
 
Nevertheless, for the sake of argument, it could be said that no, our results do not necessarily 
indicate a lack of meritocracy. Genetic associations with outcomes such as income can be an 
indicator of some degree of meritocracy. Imagine that we had found no genetic associations 
with income. What might this mean? It would indicate that the genetic variants associated 
with, say, higher intelligence, or greater conscientiousness—factors that most meritocrats 
might wish to reward—were in fact not associated with income. Therefore, our finding of a 
modest genetic association with income could be viewed as an indicator of the “meritocratic” 
notion that, at least within the population studied here, that an individual’s level of ability or 
industriousness, intelligence/personality/health—partly influenced by genetic effects—is 
associated, at least to some extent, with a higher income. Overall, though, merely knowing 
that income is related to genetic differences is just one tiny factor in answering the larger, and 
much more complicated, question of whether or not a society is meritocratic. 
 
What do you mean when you talk about “intelligence”? 
 
As discussed above, we found evidence in our study that intelligence was one of the factors 
that may be a causal factor in attaining a higher income. Indeed, one of the advances that our 
study makes is that it provides evidence that intelligence is not just correlated with income, 
but has a causal effect on income – that is to say, being more intelligent causes—to some 
extent, and on average—higher income. But what do we mean by “intelligence”? Here, we 
simply defined intelligence as a person’s score on a cognitive test, because that was how it 
was defined in the previous GWAS whose data on intelligence that we use in our analysis.  
 
Whether this definition matches with how people broadly define “intelligence” in society—or 
your own personal definition of the term—is certainly up for debate. Intelligence-type tests 
certainly miss important aspects of human ability, and they are far from the be-all and end-all 
of understanding human psychological differences. But what matters for our particular 
analysis is that people’s scores on these tests appeared to be causally related to income, 
indicating that the kind of skills that the tests require—reasoning abilities, mental speed, 
memory, and so on—are helpful in gaining socioeconomic status, at least in the context we 
studied (British people in the modern era). As we noted above, though, this doesn’t gainsay 
other influences on income that have nothing to do with intelligence, and it doesn’t gainsay 
effects of income on intelligence, rather than the other way around. All these explanations 
aren’t mutually exclusive, and it’s our view that investigating them all should be of interest to 
anyone who wants to understand societal differences. 
 
Aren’t the differences you found just due to “population 
stratification”? 
This question is a rather technical one, but it is nonetheless important. Put as simply as 
possible, if there is also a difference in income between particular sub-groups of the 
population (for example, people in the north having lower incomes than those in the south of 
the UK) and if they also happen to have slightly different genes due to chance (a well-known 
biological process called “genetic drift” can mean that this is the case), then this could lead to 
a spurious association between a variant and income. Put more technically, population 
stratification describes the existence of a systematic difference in allele frequencies (that is, 
the counts of specific types of each SNP) between population sub-groups within a larger 
population. The frequency of different variants of a gene may diverge across a population 
over the generations due to genetic drift; this can lead to genetic differences between 
subgroups within a population whereby, in one of the subgroups a particular allele may be 
very rare but for another subgroup, within the same population, this allele is much more 
common. This can be very misleading, and it was therefore important in our study to take 
steps to minimize, and to test for, these population stratification effects. 
 
We used two methods to limit the effect that population stratification had on our results. First, 
we ensured that all our participants originated from a similar ancestral background. In this 
case, all our participants were white British individuals. Second, we controlled for the degree 
to which genetic clustering occurred by including 40 principal components derived from the 
genotyped DNA-SNP data in our analysis. By doing this, we sought to break the association 
between SNPs and a phenotype that could have been caused by population stratification. 
Finally, we tested for population stratification using a method called linkage disequilibrium 
score regression (LDSC)18. LDSC is used to test whether the results of a GWAS are due to 
population stratification or are due to many variants each associated with a small effect (what 
is termed polygenicity). In our study we used LDSC regression, and the results indicated that 
over 92% of the signal we identified in our GWAS on income was due to a large number of 
genetic variants each exerting a small effect (i.e., a polygenic effect) rather than population 
stratification. 
 
Isn’t research like this going to lead to discrimination of against those 
who have certain genetic variants?  
Unfortunately, a lot of scientific research has the potential to be misused or even abused. 
Even a study aiming to identify genetic variants linked with Alzheimer’s disease could be 
abused to discriminate against those who have variants that predispose them towards this 
illness; for example, such carriers might be subject to an increased cost of health insurance.  
Importantly, research into the genetic basis of traits such as income can also facilitate a 
reduction in discrimination, precisely because the effect sizes of genetic effects that act on 
these traits becomes a known variable. In the current study, we found that genetic effects 
accounted for around only 7.5% of income differences in Great Britain today and that these 
genetic effects overlapped with intelligence as well as physical and mental health. This would 
mean that ignorant and incorrect arguments that would be used to discriminate against those 
with low income on the basis that inequality is built into our DNA19 are empirically falsified 
by our study for two reasons. First, the genetic variants tested account for only 7.5% of 
income in this population sample. Secondly, as seen in our Figure 7A, those with a high 
polygenic score for income often earn less that those with a low polygenic score for income; 
that’s what happens when there are only small associations between variables.  
We emphasize the fact that we are describing the world as it is, not how it could be; we are 
also describing results that apply to a specific context, and not others. Under different 
circumstances, the genetic effects could be smaller or larger, and so could people’s incomes. 
Regardless of any effects of genetics, those circumstances are, to a very substantial extent, 
under our and others’ control. 
What are the practical applications of this research? 
 
At present, there are none.  
We do not test any practical applications of our genetic knowledge in this study, and nor do 
we advocate for any. This is basic (as opposed to applied) science, finding links and causes 
among interesting and important variables, and building a picture of how genes relate to 
different phenotypes. The study does not include an intervention to attempt to improve those 
phenotypes, or anything close to it. Should this research translate towards anything practical, 
it will be a long time in the future, and after a great deal more research, as well as careful and 
ethical testing of every step along the way.  























Gene sets that withstood Bonferroni correction are highlighted in bold. 30 general tissue types were 
created using gene expression data based on GTEx RNA-seq data. Significant = 1, indicates tissue 
groupings that withstood Bonferroni correction.
Tissue group Beta Standard error of Beta P value Significant 
Brain 0.034 0.008 1.31×10−5 1 
Testis 0.023 0.007 3.17×10−4 1 
Pituitary 0.029 0.011 0.002 0 
Ovary 0.028 0.014 0.022 0 
Thyroid 0.017 0.015 0.137 0 
Uterus 0.018 0.017 0.146 0 
Pancreas 0.009 0.011 0.200 0 
Cervix Uteri 0.012 0.025 0.318 0 
Muscle 0.003 0.008 0.370 0 
Prostate 0.004 0.021 0.420 0 
Stomach 0.003 0.019 0.441 0 
Blood 0.001 0.007 0.466 0 
Adrenal Gland 0.000 0.013 0.507 0 
Nerve -0.003 0.015 0.575 0 
Blood Vessel -0.006 0.017 0.630 0 
Colon -0.009 0.025 0.644 0 
Fallopian Tube -0.010 0.021 0.680 0 
Small Intestine -0.013 0.014 0.835 0 
Bladder -0.023 0.022 0.858 0 
Esophagus -0.034 0.028 0.889 0 
Vagina -0.024 0.019 0.895 0 
Skin -0.019 0.014 0.915 0 
Heart -0.017 0.012 0.922 0 
Liver -0.011 0.008 0.925 0 
Kidney -0.019 0.013 0.934 0 
Breast -0.046 0.026 0.961 0 
Lung -0.028 0.015 0.970 0 
Adipose Tissue -0.038 0.020 0.972 0 
Spleen -0.019 0.010 0.975 0 
Salivary Gland -0.031 0.015 0.981 0 
 
Supplementary Table 2. MAGMA gene-property analysis for household income aiming to 
identify the cell types that are associated with differences in income.  
Cell Type P Enrichment one Tailed Significant 
Medium Spiny Neurons 7.67×10−5 1 
Serotonergic Neurons 0.002 1 
Embryonic Dopaminergic Neurons 0.004 0 
Somatosensory Cortex Pyramidal 
Neurons 
0.009 0 
Cortical Interneurons 0.009 0 
Neuronal Progenitor 0.013 0 
Striatal Interneuron 0.023 0 
Oligodendrocyte Precursor 0.028 0 
Hypothalamic GABAergic Neurons 0.037 0 
Pyramidal (CA1) 0.037 0 
Dopaminergic Neuroblast 0.045 0 
Adult Dopaminergic Neurons 0.057 0 
Embryonic Midbrain Nucleus Neurons 0.061 0 
Neuroblasts 0.063 0 
Embryonic GABAergic Neurons 0.065 0 
Oxytocin / Vasopressin Neurons 0.087 0 
Hypothalamic Dopaminergic Neurons 0.123 0 
Radial Glia Like 0.259 0 
Oligodendrocytes 0.388 0 
Hypoth. Glutamatergic Neurons 0.510 0 
Endothelial-Mural 0.545 0 
Microglia 0.596 0 
Vascular Leptomeningeal Cells 0.604 0 
Astrocytes / Ependymal 0.657 0 
Significant = 1, indicates gene sets that withstood Bonferroni correction. 










A total of 11 general development stages were created using gene expression data based on the 
BrainSpan data (http://www.brainspan.org/static/download).  
General developmental stages of brain samples Beta SE P 
Early prenatal 0.029 0.013 0.014 
Early mid-prenatal 0.038 0.016 0.008 
Late mid-prenatal 0.032 0.022 0.066 
Late prenatal -0.017 0.027 0.739 
Early infancy -0.092 0.071 0.904 
Late infancy -0.007 0.041 0.566 
Early childhood -0.046 0.022 0.981 
Late childhood -0.070 0.034 0.980 
Adolescence -0.023 0.038 0.722 
Young adulthood -0.004 0.034 0.549 
Middle adulthood -0.022 0.025 0.816 






















Gene sets that withstood Bonferroni correction are highlighted in bold. 29 age groups were created 
using gene expression data based on the BrainSpan data (http://www.brainspan.org/static/download). 
PCW, post conception weeks.
Ages of brain samples Beta SE P 
8 PCW 0.0001 0.0002 0.371 
9 PCW 0.0002 0.0003 0.250 
12 PCW 0.0001 0.0003 0.330 
13 PCW 0.0001 0.0003 0.372 
16 PCW 0.0002 0.0003 0.273 
17 PCW 0.0002 0.0004 0.270 
19 PCW 0.0001 0.0002 0.383 
21 PCW 0.0002 0.0004 0.317 
24 PCW 0.0002 0.0003 0.284 
26 PCW -0.0004 0.0007 0.742 
37 PCW 0.0001 0.0003 0.366 
4 Months -0.0003 0.0008 0.664 
10 Months -0.0001 0.0004 0.595 
1 Year 0.0003 0.0005 0.274 
2 Years -0.0004 0.0003 0.913 
3 Years -0.0003 0.0003 0.835 
4 Years -0.0002 0.0003 0.761 
8 Years -0.0004 0.0004 0.827 
11 Years 0.0000 0.0005 0.468 
13 Years 0.0001 0.0005 0.412 
15 Years 0.0003 0.0005 0.300 
18 Years -0.0003 0.0004 0.791 
19 Years 0.0000 0.0004 0.469 
21 Years 0.0001 0.0005 0.454 
23 Years -0.0003 0.0005 0.741 
30 Years 0.0000 0.0004 0.472 
36 Years 0.0001 0.0005 0.446 
37 Years 0.0002 0.0005 0.384 
40 Years -0.0003 0.0004 0.798 
Supplementary Table 5. Analysis of continuous annotations by quintile for household income. 
Statistical significance was derived using a Bonferroni correction (α = 0.01) within each quintile 
where 1 = Yes; 0 = No.
Grouping Quintile Enrichment Enrichment SE Enrichment P-value Significant 
Predicted Allele Age 1st 1.415 0.108 2.57×10−4 1 
Predicted Allele Age 2nd 1.216 0.040 3.33×10−7 1 
Predicted Allele Age 3rd 1.067 0.009 6.91×10−16 1 
Predicted Allele Age 4th 0.884 0.044 0.009 0 
Predicted Allele Age 5th 0.418 0.103 1.21×10−7 0 
Background Selection 1st 0.823 0.040 1.58×10−6 0 
Background Selection 2nd 0.906 0.021 2.57×10−6 0 
Background Selection 3rd 1.015 0.015 0.299 0 
Background Selection 4th 1.089 0.018 9.81×10−8 1 
Background Selection 5th 1.171 0.053 0.001 1 
Recombination rate 1st 0.949 0.043 0.251 0 
Recombination rate 2nd 1.022 0.034 0.519 0 
Recombination rate 3rd 1.045 0.033 0.165 0 
Recombination rate 4th 1.086 0.024 1.99×10−4 1 
Recombination rate 5th 0.899 0.101 0.306 0 
LDD AFR 1st 1.479 0.058 5.38×10−12 1 
LDD AFR 2nd 1.200 0.020 7.36×10−16 1 
LDD AFR 3rd 1.033 0.011 0.002 1 
LDD AFR 4th 0.841 0.025 3.30×10−8 0 
LDD AFR 5th 0.446 0.051 2.62×10−18 0 
Nucleotide Diversity 1st 1.456 0.046 2.47×10−23 1 
Nucleotide Diversity 2nd 1.219 0.023 3.79×10−20 1 
Nucleotide Diversity 3rd 1.032 0.010 0.003 1 
Nucleotide Diversity 4th 0.850 0.017 3.40×10−20 0 
Nucleotide Diversity 5th 0.410 0.063 2.97×10−19 0 
CpG Content 1st 0.840 0.034 1.52×10−5 0 
CpG Content 2nd 0.991 0.024 0.709 0 
CpG Content 3rd 0.998 0.019 0.906 0 
CpG Content 4th 0.939 0.023 0.007 0 
CpG Content 5th 1.232 0.055 4.32×10−5 1 
Supplementary Table 6. Showing the enrichment of household income for 13 brain annotations 
based on the GTEx database. 
Multiple comparisons were controlled for using a Bonferroni correction across the 13 annotations (α = 
0.003846154) where 1 = Yes; 0 = No. 
 
Brain Region Coefficient Coefficient SE Coefficient P-value Significant 
Brain Cortex 3.38×10−9 1.05×10−9 0.001 1 
Brain Frontal Cortex (BA9) 2.21×10−9 1.02×10−9 0.015 0 
Brain Cerebellar Hemisphere 2.52×10−9 1.25×10−9 0.022 0 
Brain Nucleus accumbens (basal 
ganglia) 
2.05×10−9 1.45×10−9 0.078 0 
Brain Anterior cingulate cortex 
(BA24) 
1.45×10−9 1.03×10−9 0.081 0 
Brain Cerebellum 1.51×10−9 1.30×10−9 0.122 0 
Brain Putamen (basal ganglia) 3.96×10−10 1.53×10−9 0.398 0 
Brain Amygdala 3.18×10−12 1.24×10−9 0.499 0 
Brain Caudate (basal ganglia) -2.14×10−10 1.45×10−9 0.559 0 
Brain Spinal cord (cervical c-1) -5.41×10−10 1.07×10−9 0.693 0 
Brain Hypothalamus -2.72×10−9 1.01×10−9 0.996 0 
Brain Substantia nigra -2.76×10−9 1.01×10−9 0.997 0 
Brain Hippocampus -3.25×10−9 9.42×10−10 1.000 0 
Supplementary Table 7. Showing the enrichment of household income for 3 brain cell types 
taken from Cahoy et al. (2008).  
Multiple comparisons were controlled for using a Bonferroni correction across the 3 annotations (α = 
0.01666667) where 1 = Yes; 0 = No.
Brain Cell Type Coefficient Coefficient SE Coefficient P-value Significant 
Neuron 4.19×10−9 1.30×10−9 0.001 1 
Astrocyte -1.26×10−10 1.29×10−9 0.539 0 
Oligodendrocyte -9.05×10−10 1.33×10−9 0.752 0 
 
Supplementary Table 8. The results of the Mendelian Randomisation analysis performed on 
intelligence and income using 19 SNPs from restricted set of 95k individuals.  
Section A: Causal effect of intelligence on income (19 SNPs from restricted set of 95k individuals). 
 
N SNPs Beta SE P 
MR Egger 19 -0.079 0.222 0.73 
Weighted median 19 0.193 0.040 1.86×10−6 
Inverse variance weighted 19 0.213 0.063 7.63×10−4 
Simple mode 19 0.172 0.067 0.02 
Weighted mode 19 0.161 0.061 0.02      
Section B: Heterogeneity statistics 
Method Q Q df P 
 
Maximum likelihood 120.0 18 4.28×10−17 
 
MR Egger 120.5 17 1.22×10−17 
 
Inverse variance weighted 133.8 18 1.00×10−19 
 
IVW radial 120.5 18 3.34×10−17 
 
     
Section C: Egger Intercept for effect of intelligence on income  
Intercept SE P 
 
Egger intercept 0.010 0.007 0.189 
 
Scale is 1 SD change in intelligence on a unit change in income (Income was defined as a five point 
category of 1,2,3,4,5. See Methods for full details of phenotype definition).









Phenotypic variation in income was predicted in the Generation Scotland: Scottish Family Health 
Study. The p-value cut off that generated the predictor that explained the most variance is shown in 
bold. 
 
Base Data Threshold Beta S.E. r2 P-value 
Income UK Biobank 0.01 0.111 0.012 0.0122 < 2.2×10−16  
0.05 0.132 0.012 0.0175 < 2.2×10−16  
0.1 0.143 0.012 0.0204 < 2.2×10−16  
0.5 0.135 0.012 0.0183 < 2.2×10−16  
1 0.137 0.012 0.0189 < 2.2×10−16 
MTAG Income 
     
 
0.01 0.133 0.012 0.0176 < 2.2×10−16  
0.05 0.157 0.012 0.0247 < 2.2×10−16  
0.1 0.153 0.012 0.0233 < 2.2×10−16  
0.5 0.151 0.012 0.0228 < 2.2×10−16 
  1 0.153 0.012 0.0234 < 2.2×10−16 
























A total of 30 general tissue types were created using gene expression data based on GTEx RNA-seq 
data. Significant = 1, indicates tissue groupings that withstood Bonferroni correction. 
 
Tissue group Beta Standard error of Beta P value Significant 
Brain 0.062 0.009 1.05×10−11 1 
Pituitary 0.047 0.012 6.72×10−5 1 
Testis 0.017 0.008 0.016 0 
Ovary 0.031 0.016 0.031 0 
Muscle 0.008 0.009 0.177 0 
Nerve 0.011 0.018 0.262 0 
Uterus 0.013 0.022 0.268 0 
Pancreas 0.007 0.012 0.269 0 
Adrenal Gland 0.005 0.016 0.367 0 
Heart 0.003 0.014 0.426 0 
Blood Vessel 0.003 0.021 0.447 0 
Colon 0.001 0.032 0.487 0 
Cervix Uteri -0.007 0.032 0.592 0 
Blood -0.002 0.008 0.600 0 
Thyroid -0.006 0.019 0.617 0 
Prostate -0.009 0.027 0.634 0 
Bladder -0.020 0.027 0.771 0 
Skin -0.013 0.017 0.780 0 
Esophagus -0.031 0.036 0.804 0 
Stomach -0.021 0.023 0.817 0 
Fallopian Tube -0.030 0.027 0.863 0 
Vagina -0.026 0.024 0.869 0 
Breast -0.044 0.033 0.906 0 
Salivary Gland -0.030 0.018 0.951 0 
Adipose Tissue -0.041 0.025 0.951 0 
Spleen -0.020 0.011 0.957 0 
Small Intestine -0.030 0.017 0.964 0 
Kidney -0.033 0.015 0.988 0 
Liver -0.020 0.009 0.989 0 
Lung -0.044 0.018 0.993 0 
Supplementary Table 11. MAGMA gene-property analysis for the MTAG analysis of household 
income.  
A total of 11 general development stages were created using gene expression data based on the 
BrainSpan data (http://www.brainspan.org/static/download). Significant = 1, indicates groupings that 
withstood Bonferroni correction.
General developmental stages of brain samples Beta SE P Significant 
Early prenatal 0.037 0.016 0.011 0 
Early mid-prenatal 0.058 0.019 0.002 1 
Late mid-prenatal 0.058 0.027 0.017 0 
Late prenatal -0.057 0.035 0.948 0 
Early infancy -0.140 0.100 0.920 0 
Late infancy 0.020 0.056 0.364 0 
Early childhood -0.078 0.028 0.998 0 
Late childhood -0.059 0.045 0.903 0 
Adolescence -0.039 0.051 0.779 0 
Young adulthood -0.002 0.045 0.518 0 
Middle adulthood -0.037 0.032 0.872 0 























A total of 29 age groups were created using gene expression data based on the BrainSpan data 
(http://www.brainspan.org/static/download). Groupings that withstood Bonferroni are highlighted in 
bold.
Ages of brain samples Beta SE P 
8 pcw 7.53×10−5 0.0003 0.391 
9 pcw 0.0003 0.0003 0.144 
12 pcw 0.0003 0.0003 0.130 
13 pcw 0.0002 0.0003 0.215 
16 pcw 0.0003 0.0003 0.165 
17 pcw 0.0003 0.0004 0.182 
19 pcw -5.36×10−5 0.0002 0.592 
21 pcw 0.0005 0.0004 0.094 
24 pcw 0.0003 0.0003 0.170 
26 pcw -0.0010 0.0007 0.917 
37 pcw -9.67×10−6 0.0003 0.511 
4 mos -1.72×10−5 0.0008 0.509 
10 mos 0.0002 0.0005 0.350 
1 yrs 0.0009 0.0006 0.067 
2 yrs -0.0008 0.0003 0.996 
3 yrs -0.0006 0.0004 0.959 
4 yrs -0.0005 0.0003 0.931 
8 yrs -0.0003 0.0004 0.760 
11 yrs 9.64×10−6 0.0005 0.493 
13 yrs 3.39×10−5 0.0005 0.475 
15 yrs 0.0005 0.0005 0.196 
18 yrs -0.0007 0.0004 0.967 
19 yrs 0.0002 0.0005 0.374 
21 yrs 0.0004 0.0005 0.241 
23 yrs -0.0004 0.0005 0.802 
30 yrs -5.26×10−5 0.0004 0.555 
36 yrs 0.0002 0.0006 0.364 
37 yrs 0.0003 0.0006 0.321 
40 yrs -0.0006 0.0004 0.932 
Supplementary Table 13. Analysis of continuous annotations by quintile using the MTAG 
analysis of income. 
Statistical significance was derived using a Bonferroni correction (α = 0.01) within each quintile 
where 1 = Yes; 0 = No. 
  
 
Grouping Quintile Enrichment Enrichment SE Enrichment P-value Significant 
Predicted Allele Age 1st 1.475 0.084 1.00×10−7 1 
Predicted Allele Age 2nd 1.243 0.031 9.36×10−13 1 
Predicted Allele Age 3rd 1.069 0.007 3.39×10−27 1 
Predicted Allele Age 4th 0.861 0.034 8.52×10−5 0 
Predicted Allele Age 5th 0.352 0.080 1.20×10−13 0 
Background Selection 1st 0.741 0.029 2.70×10−20 0 
Background Selection 2nd 0.877 0.017 8.91×10−14 0 
Background Selection 3rd 1.014 0.012 0.245 0 
Background Selection 4th 1.123 0.013 5.63×10−22 1 
Background Selection 5th 1.252 0.044 2.59×10−9 1 
Recombination rate 1st 1.001 0.033 0.980 0 
Recombination rate 2nd 1.054 0.022 0.012 0 
Recombination rate 3rd 1.062 0.023 0.005 1 
Recombination rate 4th 1.083 0.019 1.24×10−5 1 
Recombination rate 5th 0.804 0.064 0.001 0 
LDD AFR 1st 1.454 0.044 2.43×10−19 1 
LDD AFR 2nd 1.187 0.015 1.42×10−25 1 
LDD AFR 3rd 1.035 0.009 2.41×10−5 1 
LDD AFR 4th 0.853 0.018 4.11×10−13 0 
LDD AFR 5th 0.472 0.041 3.97×10−29 0 
Nucleotide Diversity 1st 1.509 0.037 1.23×10−40 1 
Nucleotide Diversity 2nd 1.239 0.018 5.16×10−37 1 
Nucleotide Diversity 3rd 1.036 0.008 9.57×10−6 1 
Nucleotide Diversity 4th 0.826 0.013 1.99×10−36 0 
Nucleotide Diversity 5th 0.354 0.049 8.66×10−36 0 
CpG Content 1st 0.857 0.026 1.74×10−7 0 
CpG Content 2nd 0.994 0.018 0.744 0 
CpG Content 3rd 1.006 0.015 0.700 0 
CpG Content 4th 0.939 0.019 0.001 0 
CpG Content 5th 1.205 0.040 3.21×10−7 1 
 
 
Supplementary Table 14. Showing the enrichment of the MTAG analysis of household income 
for 13 brain annotations based on the GTEx database. 
Brain Region Coefficient Coefficient SE Coefficient P-value Significant 
Brain Cerebellar Hemisphere 4.47×10−9 1.12×10−9 3.34×10−5 1 
Brain Cortex 3.00×10−9 9.06×10−10 4.72×10−4 1 
Brain Cerebellum 3.45×10−9 1.14×10−9 0.001 1 
Brain Frontal Cortex (BA9) 1.90×10−9 8.00×10−10 0.009 0 
Brain Anterior cingulate cortex (BA24) 1.57×10−9 8.41×10−10 0.031 0 
Brain Nucleus accumbens (basal ganglia) 2.19×10−9 1.45×10−9 0.066 0 
Brain Putamen (basal ganglia) 7.54×10−10 1.52×10−9 0.310 0 
Brain Caudate (basal ganglia) -4.57×10−11 1.40×10−9 0.513 0 
Brain Amygdala -5.90×10−10 9.80×10−10 0.726 0 
Brain Spinal cord (cervical c-1) -7.30×10−10 9.46×10−10 0.780 0 
Brain Hypothalamus -1.22×10−9 8.42×10−10 0.927 0 
Brain Hippocampus -1.57×10−9 8.42×10−10 0.969 0 
Brain Substantia nigra -2.18×10−9 8.54×10−10 0.995 0 
Multiple comparisons were controlled for using a Bonferroni correction across the 13 annotations (α = 
0.003846154) where 1 = Yes; 0 = No. 
 
Supplementary Table 15. Showing the enrichment of the MTAG analysis of household income 




Multiple comparisons were controlled for using a Bonferroni correction across the 3 annotations (α = 
0.01666667) where 1 = Yes; 0 = No. 
 
Brain Cell Type Coefficient Coefficient SE Coefficient P-value Significant 
Neuron 4.30×10−9 1.09×10−9 3.95×10−5 1 
Oligodendrocyte -4.24×10−10 1.09×10−9 0.651 0 
Astrocyte -6.32×10−10 9.61×10−10 0.745 0 
Supplementary Table 16. The source of the GWAS data sets used for genetic correlations and 
mtcojo 
Phenotype Consortium/Group Reference No. of 
individuals in 
GWAS 
Intelligence CCACE Hill et al.(2018)14 248,482 
Educational Attainment SSGAC Lee et al. (2018)20 766,345 
Social Deprivation CCACE Hill et al. (2016)21 112,005 
Parents age at Death - Pilling et al. (2017)22 75,244 
Bipolar disorder Psychiatric Genetics 
Consortium (PGC) 
Sklar et al.(2011)23 7,481 cases 9,250 
controls 







MDD Psychiatric Genetics 
Consortium (PGC) 
Daly et al. (2013)25 9,240 cases 9,519 
controls 
Anorexia nervosa Genetic Consortium for 
Anorexia Nervosa (GCAN) 
Boraska et al. (2014)26 2,907 cases 
14,860 controls 
ADHD Psychiatric Genetics 
Consortium (PGC) 




ASD Psychiatric Genetics 
Consortium (PGC) 
Cross-Disorder Group 








Type 2 diabetes DIAGRAM Morris et al. (2012)30 12,171 cases 
56,862 controls 
Obesity GIANT Berndt et al. (2013)31 263,407 
Alzheimer's disease CCACE Marioni et al. (2018)32 388,324 
Self-Rated Health CCACE Harris et al. (2016)33 111,749 
Smoking (EverVsNever) Tobacco and Genetics 
Consortium 
Furberg et al. (2010)34 74,053 
Tiredness CCACE Deary et al. (2017)35 108,976 
FEV1 Spirometer Artigas et al. (2015)36 38,199 
Subjective Wellbeing  SSGAC Okbay et al. (2015)37 193,397 
BMI GIANT Locke et al. (2015)38 339,224 
Height GIANT Wood et al. (2014)39 253,288 
Head Circumference EGG Taal et al. (2012)40 10,678 
Chronotype - Jones et al. (2016)41 128,266 
Sleep Duration - Jones et al. (2016)41 128,266 
Age at First Birth SSGAC Barban et al. (2016)42 222,037 
Number of Children SSGAC Barban et al. (2016)42 318,863 
Neuroticism (As measured using a 
general factor of Neuroticism) 
CCACE Hill et al. (2019)43 270,059 
Anxiety/Tension (Special factor of 
Neuroticism) 
CCACE Hill et al. (2019)43 270,059 
Worry/Vulnerability (Special factor of 
Neuroticism) 














Supplementary Figure 1. Circos plots by chromosome illustrating genome-wide significant loci 
associated with income (Supplementary Figure 1. The most outer layer shows the Manhattan plot and 
only SNPs where P <0.05 are shown. Each of the SNPs in the genomic risk loci are colour coded 
indicating the maximum r2 with one of the independent significant SNPs in the locus with red 
indicating the highest r2 and blue the lowest r2(red r2>0.8, orange r2>0.6, green r2>0.4, and blue 
r2>0.2). SNPs shown in grey are not in LD with any of the genome wide significant SNPs. The rsID 
of the most significant lead SNP in each loci is shown. The second layer is the chromosomal ring with 
the independent genomic risk loci highlighted in blue. Next, the genes mapped by chromatin 
interactions or eQTLs are displayed. Genes mapped using chromatin interactions the gene is displayed 
in orange, with genes mapped by eQTL shown in green. Genes that are displayed in red are those 
mapped using both chromatin interactions and eQTLs. Chromatin interaction links (coloured orange 







Supplementary Figure 2A. Manhattan plot for MTAG derived income phenotype; −log10 
transformed P-values for each SNP are plotted against chromosomal location. The red line indicates 
genome-wide significance and the black line indicates suggestive associations. Supplementary 
Figure 2B. Functional annotation carried out on the independent genomic loci identified. The 
percentage of SNPs found in each of the nine functional categories is listed. Supplementary Figure 
2C. The percentage of SNPs from the independent genomic loci that fell into each of the Regulome 
DB scores categories. A lower score indicates greater evidence for that SNPs involvement in gene 
regulation. Supplementary Figure 2D. The percentage of SNPs within the independent genomic loci 
plotted against the minimum chromatic state for 127 tissue/cell types. Supplementary Figure 2E. 
Venn diagram illustrating the overlap of the genes implicated using positional mapping, eQTL 
mapping, chromatin interaction mapping, that was conducted on the independent significant loci 
identified in the SNP-based GWAS. Also shown is how these implicated genes overlap with those 
identified using the gene-based statistics derived using MAGMA.  
 
Supplementary References 
1. Di Angelantonio, E. et al. Efficiency and safety of varying the frequency of whole blood 
donation (INTERVAL): a randomised trial of 45 000 donors. The Lancet 390, 2360-2371 
(2017). 
2. Moore, C. et al. The INTERVAL trial to determine whether intervals between blood 
donations can be safely and acceptably decreased to optimise blood supply: study protocol for 
a randomised controlled trial. Trials 15, 363 (2014). 
3. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based 
linkage analyses. The American Journal of Human Genetics 81, 559-575 (2007). 
4. The Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 
68 (2015). 
5. Jun, G. et al. Detecting and Estimating Contamination of Human DNA Samples in 
Sequencing and Array-Based Genotype Data. The American Journal of Human Genetics 91, 
839-848 (2012). 
6. Astle, W.J. et al. The Allelic Landscape of Human Blood Cell Trait Variation and Links to 
Common Complex Disease. Cell 167, 1415-1429.e19 (2016). 
7. Gallacher, J. et al. A Platform for the Remote Conduct of Gene-Environment Interaction 
Studies. PLOS ONE 8, e54331 (2013). 
8. Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. 
Bioinformatics 26, 2867-2873 (2010). 
9. Loh, P.-R. et al. Efficient Bayesian mixed-model analysis increases association power in 
large cohorts. Nature Genetics 47, 284 (2015). 
10. Sniekers, S. et al. Genome-wide association meta-analysis of 78,308 individuals identifies 
new loci and genes influencing human intelligence. Nature Genetics 49, 1107 (2017). 
11. Willer, C.J., Li, Y. & Abecasis, G.R. METAL: fast and efficient meta-analysis of 
genomewide association scans. Bioinformatics 26, 2190-2191 (2010). 
12. Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex 
trait gene targets. Nature Genetics 48, 481 (2016). 
13. Watanabe, K., Taskesen, E., Bochoven, A. & Posthuma, D. Functional mapping and 
annotation of genetic associations with FUMA. Nature communications 8, 1826 (2017). 
14. Hill, W. et al. A combined analysis of genetically correlated traits identifies 187 loci and a 
role for neurogenesis and myelination in intelligence. Molecular psychiatry, 1 (2018). 
15. Hill, W.D., Weiss, A., McIntosh, A.M., Gale, C.R. & Deary, I.J. Genetic contribution to two 
factors of neuroticism is associated with affluence, better health, and longer life. bioRxiv 
(2017). 
16. Solovieff, N., Cotsapas, C., Lee, P.H., Purcell, S.M. & Smoller, J.W. Pleiotropy in complex 
traits: challenges and strategies. Nature reviews. Genetics 14, 483 (2013). 
17. Hyytinen, A., Ilmakunnas, P., Johansson, E. & Toivanen, O. Heritability of lifetime earnings. 
The Journal of Economic Inequality 17, 319-335 (2019). 
18. Bulik-Sullivan, B.K. et al. LD Score regression distinguishes confounding from polygenicity 
in genome-wide association studies. Nature genetics 47, 291-295 (2015). 
19. Leake, J. Scientists find 24 ‘golden’ genes that help you get rich. The Times, Retrieved from 
https://www.thetimes.co.uk (2019). 
20. Lee, J.J. et al. Gene discovery and polygenic prediction from a genome-wide association 
study of educational attainment in 1.1 million individuals. Nature Genetics 50, 1112-1121 
(2018). 
21. Hill, W.D. et al. Molecular genetic contributions to social deprivation and household income 
in UK Biobank. Current Biology 26, 3083-3089 (2016). 
22. Pilling, L.C. et al. Human longevity: 25 genetic loci associated in 389,166 UK biobank 
participants. Aging 9, 2504-2520 (2017). 
23. Sklar, P. et al. Large-scale genome-wide association analysis of bipolar disorder identifies a 
new susceptibility locus near ODZ4. Nature Genetics 43, 977-983 (2011). 
24. Schizophrenia Working Group of the Psychiatric Genomics, C. et al. Biological insights from 
108 schizophrenia-associated genetic loci. Nature 511, 421 (2014). 
25. Daly, J. et al. A mega-analysis of genome-wide association studies for major depressive 
disorder. Mol Psychiatry. 18(2013). 
26. Boraska, V. et al. A genome-wide association study of anorexia nervosa. Molecular 
Psychiatry 19, 1085-1094 (2014). 
27. Demontis, D. et al. Discovery of the first genome-wide significant risk loci for attention 
deficit/hyperactivity disorder. Nature Genetics 51, 63-75 (2019). 
28. Consortium, C.-D.G.o.t.P.G. Identification of risk loci with shared effects on five major 
psychiatric disorders: a genome-wide analysis. The Lancet 381, 1371-1379 (2013). 
29. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for 
coronary artery disease. Nature Genetics 43, 333-338 (2011). 
30. Morris, A.P. et al. Large-scale association analysis provides insights into the genetic 
architecture and pathophysiology of type 2 diabetes. Nature Genetics 44, 981-990 (2012). 
31. Berndt, S.I. et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits 
and provides insights into genetic architecture. Nature Genetics 45, 501 (2013). 
32. Marioni, R.E. et al. GWAS on family history of Alzheimer’s disease. Translational 
Psychiatry 8, 99 (2018). 
33. Harris, S.E. et al. Molecular genetic contributions to self-rated health. International Journal 
of Epidemiology 46, 994-1009 (2016). 
34. Furberg, H. et al. Genome-wide meta-analyses identify multiple loci associated with smoking 
behavior. Nature Genetics 42, 441-447 (2010). 
35. Deary, V. et al. Genetic contributions to self-reported tiredness. Molecular Psychiatry 23, 
609-620 (2018). 
36. Artigas, M.S. et al. Sixteen new lung function signals identified through 1000 Genomes 
Project reference panel imputation. Nature Communications 6, 8658 (2015). 
37. Okbay, A. et al. Genetic variants associated with subjective well-being, depressive symptoms, 
and neuroticism identified through genome-wide analyses. Nature Genetics 48, 624 (2016). 
38. Locke, A.E. et al. Genetic studies of body mass index yield new insights for obesity biology. 
Nature 518, 197 (2015). 
39. Wood, A.R. et al. Defining the role of common variation in the genomic and biological 
architecture of adult human height. Nature Genetics 46, 1173 (2014). 
40. Taal, H.R. et al. Common variants at 12q15 and 12q24 are associated with infant head 
circumference. Nature Genetics 44, 532-538 (2012). 
41. Jones, S.E. et al. Genome-Wide Association Analyses in 128,266 Individuals Identifies New 
Morningness and Sleep Duration Loci. PLOS Genetics 12, e1006125 (2016). 
42. Barban, N. et al. Genome-wide analysis identifies 12 loci influencing human reproductive 
behavior. Nature Genetics 48, 1462 (2016). 
43. Hill, W.D. et al. Genetic contributions to two special factors of neuroticism are associated 
with affluence, higher intelligence, better health, and longer life. Molecular Psychiatry 
(2019). 
 
 
